Phibro Animal Health Corporation (NASDAQ:PAHC) is set to announce fourth quarter earning results on Wednesday 26th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, PAHC to report 4Q20 income of $ 0.22 per share.
For the full year, analysts anticipate top line of $ 804.16 million, while looking forward to income of $ 1.13 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 812.00 million ~ $ 828.00 million, where as bottomline are predicted in a range of $ 1.15 ~ $ 1.22 per share
Click Here For More Historical Outlooks Of Phibro Animal Health Corporation
Previous Quarter Performance
Phibro Animal Health Corporation disclosed income for the third quarter of $ 0.38 per share, from the revenue of $ 210.70 million. The quarterly earnings fell 2.56 percent compared with the same quarter last year. Street analysts expected Phibro Animal Health Corporation to report income of $ 0.34 per share on revenue of $ 208.27 million for the third quarter. The bottom line results beat street analysts by $ 0.04 or 11.76 percent, at the same time, top line results outshined analysts by $ 2.43 million or 1.17 percent.
Stock Performance
Shares of Phibro Animal Health Corporation traded high $ 0.10 or 0.50 percent on Tuesday, reaching $ 20.19 with volume of 137.00 thousand shares. The stock opened positive for the day at $ 20.26, after closing the previous day trading at $ 20.09.
According to the previous trading day, closing price of $ 20.09, representing a 19.09 % increase from the 52 week low of $ 16.87 and a 39.29 % decrease over the 52 week high of $ 33.09.
The company has a market capital of $ 816.76 million and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Recent Stock Dividend Announcement
On July 27, 2020, the board of directors authorized quarterly dividend of $ 0.12 per share to holders of record as of the close of business on September 2, 2020, with payment date of September 23, 2020 and ex-dividend date on September 1, 2020.
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
